HRS-5632

· Fujian Shengdi Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for HRS-5632, covering 2026-03-05 to 2026-04-03. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Clinical Study of a Single Subcutaneous Injection of HRS-5632 in Healthy Subjects [Phase 1]